Perfusion with lipopolysaccharide differently affects the secretion of interleukin-1 beta and interleukin-1 receptor antagonist by term and preterm human placentae

G. Holcberg, A. Amash, O. Sapir, E. Sheiner, S. Levy, L. Myatt, M. Huleihel

Research output: Contribution to journalArticle

17 Scopus citations

Abstract

The aim of the present study was to examine the effect of lipopolysaccharide (LPS) on the secretion of the pro-inflammatory cytokine interleukin-1β (IL-1β) and of its natural inhibitor interleukin-1 receptor antagonist (IL-1Ra), by perfused human term and preterm placental tissue. Eight term and eight preterm placentae were collected immediately after delivery; four term and four preterm placentae were perfused with control medium (without LPS) and the other four term and four preterm placentae were perfused with medium containing LPS. The release of IL-1β into the maternal compartment by term placenta was significantly higher than the release by preterm placenta (p < 0.001). However, there were no significant differences between IL-1β levels released into the fetal compartments of term and preterm placentae. No significant differences were observed in the release of IL-1Ra into the maternal and fetal compartments of term placenta, when compared to preterm placenta. Exposure to LPS significantly decreased the capacity of term placenta to release IL-1β into the maternal compartment (p < 0.001) and increased the capacity of term placenta to release IL-1Ra into the maternal and fetal compartments (p < 0.001 and p = 0.017, respectively). However, the capacity of preterm placentae to release IL-1β and IL-Ra into the maternal and fetal compartments was not affected by LPS. IL-1β was expressed by both term and preterm placentae before and after perfusion (+/- LPS), by epithelial cells of the amnion, chorion, by syncytiotrophoblast and stromal cells of villous tissue and by the decidua. IL-1Ra in term and preterm placentae was expressed before perfusion mainly in epithelial cells of the amnion. After perfusion of term placentae (+/- LPS), additional IL-1Ra expression was seen in epithelial cells of the amnion and in syncytiotrophoblast and stromal cells of villous tissue and by the decidua. However, perfusion of preterm placentae (+/- LPS) did not affect IL-1Ra expression. The localization of IL-1β and IL-1Ra in both term and preterm human placental tissue suggests a their physiologic role. The data presented indicates that the IL-1 system in term and preterm placentae seems to be differently affected by LPS. Down-regulation in the release of the pro-inflammatory cytokine IL-1β and the up-regulation of its antagonist (IL-1Ra) may be a part of the inflammatory response to infection in human term, but not preterm, placentae. The IL-1 system in term and preterm placentae seems to be differently affected by LPS.

Original languageEnglish (US)
Pages (from-to)593-601
Number of pages9
JournalPlacenta
Volume29
Issue number7
DOIs
StatePublished - Jul 1 2008

Keywords

  • Interleukin-1 beta (IL-1β)
  • Interleukin-1 receptor antagonist (IL-1Ra)
  • Lipopolysaccharide
  • Placenta
  • Preterm delivery

ASJC Scopus subject areas

  • Reproductive Medicine
  • Obstetrics and Gynecology
  • Developmental Biology

Fingerprint Dive into the research topics of 'Perfusion with lipopolysaccharide differently affects the secretion of interleukin-1 beta and interleukin-1 receptor antagonist by term and preterm human placentae'. Together they form a unique fingerprint.

  • Cite this